Gabelli Funds’s Fusion Pharmaceuticals Inc. Common Shares FUSN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
– Sell
-146,150
Closed -$3.12M – 1125
2024
Q1
$3.12M Buy
+146,150
New +$1.75M 0.02% 558

Gabelli Funds's FUSN Position: Q2 2024 in Review

Gabelli Funds sold out of Fusion Pharmaceuticals Inc. Common Shares (FUSN) in Q2 2024, closing a stake of 146,150 shares — an estimated $3.12M sold.

Gabelli Funds first reported a position in FUSN in Q1 2024 and held it in 1 quarter. The position peaked at $3.12M in Q1 2024. 0 funds tracked by Wall St. Rank hold FUSN as of Q2 2024.

  • Gabelli Funds reported no remaining Fusion Pharmaceuticals Inc. Common Shares position as of Q2 2024 after selling out during the quarter.
  • Gabelli Funds sold 146,150 Fusion Pharmaceuticals Inc. Common Shares shares in Q2 2024, an estimated $3.12M.
  • Gabelli Funds first reported a position in Fusion Pharmaceuticals Inc. Common Shares in Q1 2024 and held it in 1 quarter.
  • Gabelli Funds's Fusion Pharmaceuticals Inc. Common Shares position peaked at $3.12M in Q1 2024.
  • 0 funds tracked by Wall St. Rank held Fusion Pharmaceuticals Inc. Common Shares as of Q2 2024.

Based on Gabelli Funds's 13F filing for Q2 2024, filed 13 Aug 2024.